Tuesday, October 13, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 20, 2026

Nebius and Parsons have been highlighted as Zacks Bull and Bear of the Day

View original at finance.yahoo.com
Nebius and Parsons have been highlighted as Zacks Bull and Bear of the Day For Immediate Release Chicago, IL – February 20, 2026 – Zacks Equity Research shares Nebius Group (NBIS) as the Bull of the Day and Parsons PSN as the Bear of the Day…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The company expects to spend between $16B - $20B in CapEx this year, with at least 60% funded from operations

    80% confidence
  • Parsons is a Zacks Rank #5 (Strong Sell) with a Zacks Style Score for Value of C and a B for Growth

    80% confidence
  • Analysts have projected revenue of $8.7B for Nebius in 2027, which would be good for 167% growth

    80% confidence
  • Investors are concerned that advances in AI could disrupt some business models, affecting tech, financial, transportation and logistics stocks

    80% confidence
  • Inflation, despite easing over the past few months, is still far from the Federal Reserve's 2% target

    80% confidence
  • Nebius Group is a Zacks Rank #2 (Buy) with an F for Value and a C for Growth

    80% confidence
  • Since 2000, Zacks' top stock-picking strategies have blown away the S&P's +7.7% average gain per year with average gains of +48.4%, +50.2% and +56.7% per year

    80% confidence
  • 2026 is expected to see sales of $3.25B for Nebius, which would be good for 508% topline growth

    80% confidence
  • Nebius has reached an annual revenue run rate of $1.25B

    80% confidence
  • A lot of stocks in the Zacks universe are seeing negative earnings estimate revisions, causing stocks with small negative revisions to fall to Zacks Rank #5 (Strong Sell)

    80% confidence
  • The AVRIDE autonomous driving system was more appropriately aggressive when it needed to be compared to Tesla autopilot

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,372 source documents archived
Query this data → isubstrate.com